Epigenetic instability may alter cell state transitions and anticancer drug resistance.

Drug resistance is a significant obstacle to successful and durable anti-cancer therapy. Targeted therapy is often effective during early phases of treatment; however, eventually cancer cells adapt and transition to drug-resistant cells states rendering the treatment ineffective. It is proposed that...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anshul Saini, James M Gallo
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/6c9e006cf9054e7b99c24469fa567e8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6c9e006cf9054e7b99c24469fa567e8f
record_format dspace
spelling oai:doaj.org-article:6c9e006cf9054e7b99c24469fa567e8f2021-12-02T19:58:01ZEpigenetic instability may alter cell state transitions and anticancer drug resistance.1553-734X1553-735810.1371/journal.pcbi.1009307https://doaj.org/article/6c9e006cf9054e7b99c24469fa567e8f2021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009307https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358Drug resistance is a significant obstacle to successful and durable anti-cancer therapy. Targeted therapy is often effective during early phases of treatment; however, eventually cancer cells adapt and transition to drug-resistant cells states rendering the treatment ineffective. It is proposed that cell state can be a determinant of drug efficacy and manipulated to affect the development of anticancer drug resistance. In this work, we developed two stochastic cell state models and an integrated stochastic-deterministic model referenced to brain tumors. The stochastic cell state models included transcriptionally-permissive and -restrictive states based on the underlying hypothesis that epigenetic instability mitigates lock-in of drug-resistant states. When moderate epigenetic instability was implemented the drug-resistant cell populations were reduced, on average, by 60%, whereas a high level of epigenetic disruption reduced them by about 90%. The stochastic-deterministic model utilized the stochastic cell state model to drive the dynamics of the DNA repair enzyme, methylguanine-methyltransferase (MGMT), that repairs temozolomide (TMZ)-induced O6-methylguanine (O6mG) adducts. In the presence of epigenetic instability, the production of MGMT decreased that coincided with an increase of O6mG adducts following a multiple-dose regimen of TMZ. Generation of epigenetic instability via epigenetic modifier therapy could be a viable strategy to mitigate anticancer drug resistance.Anshul SainiJames M GalloPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 8, p e1009307 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Anshul Saini
James M Gallo
Epigenetic instability may alter cell state transitions and anticancer drug resistance.
description Drug resistance is a significant obstacle to successful and durable anti-cancer therapy. Targeted therapy is often effective during early phases of treatment; however, eventually cancer cells adapt and transition to drug-resistant cells states rendering the treatment ineffective. It is proposed that cell state can be a determinant of drug efficacy and manipulated to affect the development of anticancer drug resistance. In this work, we developed two stochastic cell state models and an integrated stochastic-deterministic model referenced to brain tumors. The stochastic cell state models included transcriptionally-permissive and -restrictive states based on the underlying hypothesis that epigenetic instability mitigates lock-in of drug-resistant states. When moderate epigenetic instability was implemented the drug-resistant cell populations were reduced, on average, by 60%, whereas a high level of epigenetic disruption reduced them by about 90%. The stochastic-deterministic model utilized the stochastic cell state model to drive the dynamics of the DNA repair enzyme, methylguanine-methyltransferase (MGMT), that repairs temozolomide (TMZ)-induced O6-methylguanine (O6mG) adducts. In the presence of epigenetic instability, the production of MGMT decreased that coincided with an increase of O6mG adducts following a multiple-dose regimen of TMZ. Generation of epigenetic instability via epigenetic modifier therapy could be a viable strategy to mitigate anticancer drug resistance.
format article
author Anshul Saini
James M Gallo
author_facet Anshul Saini
James M Gallo
author_sort Anshul Saini
title Epigenetic instability may alter cell state transitions and anticancer drug resistance.
title_short Epigenetic instability may alter cell state transitions and anticancer drug resistance.
title_full Epigenetic instability may alter cell state transitions and anticancer drug resistance.
title_fullStr Epigenetic instability may alter cell state transitions and anticancer drug resistance.
title_full_unstemmed Epigenetic instability may alter cell state transitions and anticancer drug resistance.
title_sort epigenetic instability may alter cell state transitions and anticancer drug resistance.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/6c9e006cf9054e7b99c24469fa567e8f
work_keys_str_mv AT anshulsaini epigeneticinstabilitymayaltercellstatetransitionsandanticancerdrugresistance
AT jamesmgallo epigeneticinstabilitymayaltercellstatetransitionsandanticancerdrugresistance
_version_ 1718375781948719104